STD Self-Diagnostics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 January 31
SKU : MD3905
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
Why is the STD self-diagnostics market growing?
The STD self-diagnostics market is growing due to several factors, including the increasing prevalence of STIs, rising awareness and patient education, and the demand for rapid and accurate tests.
What are the benefits of self-testing for STDs?
Self-testing for STDs offers several benefits, such as privacy, convenience, and faster results compared to traditional clinic visits. It also empowers individuals to take control of their sexual health and seek timely treatment if needed.
What are the different types of STD self-diagnostic tests available?
Various types of STD self-diagnostic tests are available, including urine tests, blood tests, and swab tests. Each test targets specific STIs, and it's important to choose the appropriate test based on your individual needs and risk factors.
Who are the Key Players of self-testing for STDs?
Some of the key players which are contributing to the growth of the market include F. Hoffmann-La Roche, Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, Affymetrix, BioMerieux, Cepheid Inc., Alere Inc., DiaSorin, and Orasure.